Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | Mitral Valve Replacement | Research article

Left atrial geometry in an ovine ischemic mitral regurgitation model: implications for transcatheter mitral valve replacement devices with a left atrial anchoring mechanism

Authors: Akito Imai, Arash Khamooshian, Keitaro Okamoto, Yoshiaki Saito, Inez J. Wijdh-den Hamer, Massimo A. Mariani, Matthew J. Gillespie, Robert C. Gorman, Joseph H. Gorman III, Wobbe Bouma

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Background

Transcatheter mitral valve replacement (TMVR) is a challenging, but promising minimally invasive treatment option for patients with mitral valve disease. Depending on the anchoring mechanism, complications such as mitral leaflet or chordal disruption, aortic valve disruption or left ventricular outflow tract obstruction may occur. Supra-annular devices only anchor at the left atrial (LA) level with a low risk of these complications. For development of transcatheter valves based on LA anchoring, animal feasibility studies are required. In this study we sought to describe LA systolic and diastolic geometry in an ovine ischemic mitral regurgitation (IMR) model using magnetic resonance imaging (MRI) and echocardiography in order to facilitate future research focusing on TMVR device development for (I)MR with LA anchoring mechanisms.

Methods

A group of 10 adult male Dorsett sheep underwent a left lateral thoracotomy. Posterolateral myocardial infarction was created by ligation of the left circumflex coronary artery, the obtuse marginal and diagonal branches. MRI and echocardiography were performed at baseline and 8 weeks after myocardial infarction (MI).

Results

Six animals survived to 8 weeks follow-up. All animals had grade 2 + or higher IMR 8 weeks post-MI. All LA geometric parameters did not change significantly 8 weeks post-MI compared to baseline. Diastolic and systolic interpapillary muscle distance increased significantly 8 weeks post-MI.

Conclusions

Systolic and diastolic LA geometry do not change significantly in the presence of grade 2 + or higher IMR 8 weeks post-MI. These findings help facilitate future tailored TMVR device development with LA anchoring mechanisms.
Literature
1.
go back to reference Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65.CrossRef Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65.CrossRef
2.
go back to reference Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease–current management and future challenges. Lancet. 2016;387:1324–34.CrossRef Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease–current management and future challenges. Lancet. 2016;387:1324–34.CrossRef
3.
go back to reference Chiarito M, Pagnesi M, Martino EA, Pighi M, Scotti A, Biondi-Zoccai G, et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart. 2018;104:306–12.CrossRef Chiarito M, Pagnesi M, Martino EA, Pighi M, Scotti A, Biondi-Zoccai G, et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart. 2018;104:306–12.CrossRef
4.
go back to reference Wyler von Ballmoos MC, Kalra A, Reardon MJ. Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR). Ann Cardiothorac Surg. 2018;7:724–30.CrossRef Wyler von Ballmoos MC, Kalra A, Reardon MJ. Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR). Ann Cardiothorac Surg. 2018;7:724–30.CrossRef
5.
go back to reference Ye J, Cheung A, Yamashita M, Wood D, Peng D, Gao M, et al. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv. 2015;8:1735–44.CrossRef Ye J, Cheung A, Yamashita M, Wood D, Peng D, Gao M, et al. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv. 2015;8:1735–44.CrossRef
6.
go back to reference Eleid MF, Whisenant BK, Cabalka AK, Williams MR, Nejjari M, Attias D, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10:1932–42.CrossRef Eleid MF, Whisenant BK, Cabalka AK, Williams MR, Nejjari M, Attias D, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10:1932–42.CrossRef
7.
go back to reference Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–51.CrossRef Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–51.CrossRef
8.
go back to reference Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, et al. Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation. EuroIntervention. 2019;15:e1065–71.CrossRef Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, et al. Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation. EuroIntervention. 2019;15:e1065–71.CrossRef
9.
go back to reference Perpetua EM, Reisman M. The Tendyne transcatheter mitral valve implantation system. EuroIntervention. 2015;11(Suppl W):W78–9.CrossRef Perpetua EM, Reisman M. The Tendyne transcatheter mitral valve implantation system. EuroIntervention. 2015;11(Suppl W):W78–9.CrossRef
10.
go back to reference Piazza N, Overtchouk P, Ben-Shoshan J. Predicting TMVR outcomes—the Tendyne experience. EuroIntervention. 2019;15:e1033–4.CrossRef Piazza N, Overtchouk P, Ben-Shoshan J. Predicting TMVR outcomes—the Tendyne experience. EuroIntervention. 2019;15:e1033–4.CrossRef
11.
go back to reference El Hajj SC, Eleid MF. Transcatheter mitral valve replacement: an update on the current literature. Curr Treat Options Cardiovasc Med. 2019;21:35.CrossRef El Hajj SC, Eleid MF. Transcatheter mitral valve replacement: an update on the current literature. Curr Treat Options Cardiovasc Med. 2019;21:35.CrossRef
12.
go back to reference Ferreira-Neto AN, Dagenais F, Bernier M, Dumont E, Freitas-Ferraz AB, Rodes-Cabau J. Transcatheter mitral valve replacement with a new supra-annular valve: first-in-human experience with the AltaValve system. JACC Cardiovasc Interv. 2019;12:208–9.CrossRef Ferreira-Neto AN, Dagenais F, Bernier M, Dumont E, Freitas-Ferraz AB, Rodes-Cabau J. Transcatheter mitral valve replacement with a new supra-annular valve: first-in-human experience with the AltaValve system. JACC Cardiovasc Interv. 2019;12:208–9.CrossRef
13.
go back to reference Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, Dagenais F, Paradis JM, Bernier M, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019;8:e013332.PubMedPubMedCentral Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, Dagenais F, Paradis JM, Bernier M, et al. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019;8:e013332.PubMedPubMedCentral
14.
go back to reference Gorman JH 3rd, Gorman RC, Jackson BM, Hiramatsu Y, Gikakis N, Kelley ST, et al. Distortions of the mitral valve in acute ischemic mitral regurgitation. Ann Thorac Surg. 1997;64:1026–31.CrossRef Gorman JH 3rd, Gorman RC, Jackson BM, Hiramatsu Y, Gikakis N, Kelley ST, et al. Distortions of the mitral valve in acute ischemic mitral regurgitation. Ann Thorac Surg. 1997;64:1026–31.CrossRef
15.
go back to reference Gorman JH 3rd, Gorman RC, Plappert T, Jackson BM, Hiramatsu Y, StJohn-Sutton MG, et al. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 1998;115:615–22.CrossRef Gorman JH 3rd, Gorman RC, Plappert T, Jackson BM, Hiramatsu Y, StJohn-Sutton MG, et al. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 1998;115:615–22.CrossRef
16.
go back to reference Siefert AW, Jimenez JH, Koomalsingh KJ, Aguel F, West DS, Shuto T, et al. Contractile mitral annular forces are reduced with ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2013;146:422–8.CrossRef Siefert AW, Jimenez JH, Koomalsingh KJ, Aguel F, West DS, Shuto T, et al. Contractile mitral annular forces are reduced with ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2013;146:422–8.CrossRef
Metadata
Title
Left atrial geometry in an ovine ischemic mitral regurgitation model: implications for transcatheter mitral valve replacement devices with a left atrial anchoring mechanism
Authors
Akito Imai
Arash Khamooshian
Keitaro Okamoto
Yoshiaki Saito
Inez J. Wijdh-den Hamer
Massimo A. Mariani
Matthew J. Gillespie
Robert C. Gorman
Joseph H. Gorman III
Wobbe Bouma
Publication date
01-12-2021

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue